Common LRT infection characterized by inflammation of the lung tissue
Aetiology
- Streptococcus pneumoniae (70%) - most common, community acquired
- Haemophilus influenza (5%) - usually the elderly and patients with COPD
- Staph. aureus (4%) - common in PWIDs, often following influenza

Atypicals
- Legionella - inhalation of contaminated water droplets
- Mycoplasma pneumonia - children and young adults, peaks every 4 years
- Coxiella burneti (Q fever) - farming
- Chlamydia psittaci - birds (pets)
- Klebsiella - aspiration (e.g. from alcoholism)
- Pneumocytis jiroveci - immunocompromised e.g. AIDS patients
Pathophysiology
- Infection → inflammatory exudation → consolidation
Lobar pneumonia
- Confluent consolidation involving a complete lung lobe
- Most commonly Streptococcus pneumoniae (community acquired), classically in otherwise healthy young adults
Bronchopneumonia
- Infection starting in the airways and spreading to adjacent alveolar lung
- Most often seen in the context of pre-existing disease
Clinical presentation
Symptoms
- Fever, chills
- Cough ± sputum (purulent, rusty)
- Dyspnea
- Pleuritic chest pain
- Fatigue, myalgia
- Elderly: confusion, falls
Signs
- Tachypnea, tachycardia
- Reduced chest expansion
- Bronchial breath sounds
- Crackles
- Dullness to percussion
- ↑ vocal fremitus
Investigations
- General investigations are not necessary for the majority of patients who are managed in the community
- When a patient is admitted to hospital:
- FBCs, CRP, U+Es
- CXR
- If moderate/severe - sputum examination and culture, blood culture, legionella and pneumococcal urinary antigens
CURB 65 - Risk Score
- Confusion
- Urea ≳ 7 mmol
- Resp. rate > 30
- BP - systolic < 90, diastolic ≲ 60
- ≳65 years
Interpretation
- 0–1: Outpatient
- 2: Inpatient
- ≥3: Severe → ICU
Sputum
- Sterptococcus pneumonia - rust coloured sputum
- Pseudomonas, Haemophilus - green sputum
- Klebsiella - red currant-jelly sputum
- Anaerobes - foul smelling and bad-tasting sputum
Management
CAP (pneumococcal)
Outpatient (No Comorbidities)
- Amoxicillin 1 g PO 3x1
- Doxycycline 100 mg PO 2x1
- Azithromycin 500 mg PO (day 1) → 250 mg PO 1x1
Outpatient (With Comorbidities)
- Amoxicillin-clavulanate / Cephalosporin + Macrolide or Doxycycline
- Respiratory fluoroquinolone
Inpatient
- β-lactam / Cephalosporin + Macrolide
- Respiratory fluoroquinolone
- β-lactam / Cephalosporin + Doxycycline
📄 Empiric Antibiotic Options (Respiratory Infections)
Drug Class | Drug | Dose | Frequency |
β-lactam / β-lactamase inhibitor | Amoxicillin–clavulanate | 500 mg / 125 mg | 3×1 |
ㅤ | ㅤ | 875 mg / 125 mg | 2×1 |
ㅤ | ㅤ | 2000 mg / 125 mg | 2×1 |
Macrolide | Azithromycin | 500 mg (Day 1) | 1x1 |
ㅤ | ㅤ | 250 mg (Day 2–5) | 1x1 |
ㅤ | Clarithromycin | 500 mg | 2x1 |
ㅤ | Clarithromycin XR | 1000 mg | 1x1 |
Cephalosporin (oral) | Cefpodoxime | 200 mg | 2x1 |
ㅤ | Cefuroxime | 500 mg | 2x1 |
Respiratory Fluoroquinolone | Levofloxacin | 750 mg | 1x1 |
ㅤ | Moxifloxacin | 400 mg | 1x1 |
ㅤ | Gemifloxacin | 320 mg | 1x1 |
Hospital acquired (extended gram-negative cover)
- Non-severe - PO amoxicillin (if penicillin allergic: PO doxycycline)
- Severe - IV amoxicillin + gentamicin (if penicillin allergic: PO doxycycline + gentamicin)
Aspiration pneumonia (anaerobic cover)
- Non-severe - PO amoxicillin + metronidazole (if penicillin allergic: doxycycline + metronidazole)
- Severe - IV amoxicillin + gentamicin + metronidazole (if penicillin allergic: PO doxycycline + IV gentamicin + metronidazole)
Atypicals
- Doxycycline
- Except Legionella - clarithromycin/erythromycin or levofloxin